If we can break above .08, then technically .14 and .34 are possible as shorts from the past year must cover if/when emergence from BK is secured. Prehistin needs a production agreement and sales and marketing agreement for a revenue stream. This is what will save this company and investors. The catastrophic fall from $1.24 to .80 then to .02 once Phase III not conclusive was criminal IMO. If production, distribution and revenue had been the priority the past 3-4 years this company would have serious revenue by now. Lets hope revenue is the priority by management and does not require dilution of shareholder value to get there. Cash flow is everything in this market. Pink sheets with no cash flow are dead. Even companies with significant cash flow and revenue are down 40-80% the past 1.5 years.